Cargando…

Overcoming Shellfish Allergy: How Far Have We Come? †

Shellfish allergy caused by undesirable immunological responses upon ingestion of crustaceans and mollusks is a common cause of food allergy, especially in the Asia-Pacific region. While the prevalence of shellfish allergy is increasing, the mainstay of clinical diagnosis for these patients includes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wai, Christine Y.Y., Leung, Nicki Y.H., Chu, Ka Hou, Leung, Patrick S.C., Leung, Agnes S.Y., Wong, Gary W.K., Leung, Ting Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139905/ https://www.ncbi.nlm.nih.gov/pubmed/32210187 http://dx.doi.org/10.3390/ijms21062234

Ejemplares similares

Diagnosis of fish and shellfish allergies
por: Tong, Wai Sze, et al.
Publicado: (2018)

Modulating Shrimp Tropomyosin-Mediated Allergy: Hypoallergen DNA Vaccines Induce Regulatory T Cells to Reduce Hypersensitivity in Mouse Model
por: Wai, Christine Y.Y., et al.
Publicado: (2019)

Seafood Allergy in Asia: Geographical Specificity and Beyond
por: Wai, Christine Y. Y., et al.
Publicado: (2021)

Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML
por: Lam, Stephen S.Y., et al.
Publicado: (2020)

Updated consensus statements on COVID-19 Vaccine Allergy Safety in Hong Kong
por: Chiang, Valerie, et al.
Publicado: (2022)

Stem-cell transplantation in multiple myeloma: how far have we come?
por: Soekojo, Cinnie Y., et al.
Publicado: (2019)

Comprehending the allergen repertoire of shrimp for precision molecular diagnosis of shrimp allergy
por: Wai, Christine Y. Y., et al.
Publicado: (2022)

Immunotherapy in myeloma: how far have we come?
por: Franssen, Laurens E., et al.
Publicado: (2019)

Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021)

Intravenous iron therapy: how far have we come?
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

Best Pharmaceuticals for Children: How Far Have We Come?
por: Mazer-Amirshahi, Maryann, et al.
Publicado: (2014)

Understanding Bioluminescence in Dinoflagellates—How Far Have We Come?
por: Valiadi, Martha, et al.
Publicado: (2013)

Candida glabrata Biofilms: How Far Have We Come?
por: Rodrigues, Célia F., et al.
Publicado: (2017)

Gene Delivery to the Skin – How Far Have We Come?
por: Ain, Qurrat Ul, et al.
Publicado: (2021)

Calcium imaging analysis – how far have we come?
por: Robbins, Miranda, et al.
Publicado: (2021)

Not all shellfish "allergy" is allergy!
por: Woo, Chee K, et al.
Publicado: (2011)

Immunization with Hypoallergens of Shrimp Allergen Tropomyosin Inhibits Shrimp Tropomyosin Specific IgE Reactivity
por: Wai, Christine Y. Y., et al.
Publicado: (2014)

Paediatric Surgery on the African Continent: How Far Have We Come; How Far Can We Go?
por: Numanoglu, Alp
Publicado: (2023)

Cell therapies for Parkinson's disease: how far have we come?
por: Stoker, Thomas B, et al.
Publicado: (2016)

Metals and Alzheimer’s Disease: How Far Have We Come in the Clinic?
por: Adlard, Paul A., et al.
Publicado: (2018)

Understanding blast-induced neurotrauma: how far have we come?
por: Cernak, Ibolja
Publicado: (2017)

Delineating the Risk of Lupus Nephritis: How Far Have We Come?
por: Lee, Jisoo
Publicado: (2021)

Biomaterials for Testicular Bioengineering: How far have we come and where do we have to go?
por: Horvath-Pereira, Bianca de Oliveira, et al.
Publicado: (2023)

Providing Effective Environmental Enrichment to Pigs: How Far Have We Come?
por: van de Weerd, Heleen, et al.
Publicado: (2019)

Place Identity: How Far Have We Come in Exploring Its Meanings?
por: Peng, Jianchao, et al.
Publicado: (2020)

Research for Prevention of Oral/Dental Diseases: How Far Have We Come?
por: Schwendicke, F., et al.
Publicado: (2019)

Thermal Ablation for Papillary Thyroid Microcarcinoma: How Far We Have Come?
por: Min, Yu, et al.
Publicado: (2020)

Editorial: Functional neuroimaging in psychiatric practice: How far have we come?
por: Kundu, Prantik
Publicado: (2023)

Dog and Cat Allergies: Current State of Diagnostic Approaches and Challenges
por: Chan, Sanny K., et al.
Publicado: (2018)

How Different Parts of the World Provide New Insights Into Food Allergy
por: Tham, Elizabeth Huiwen, et al.
Publicado: (2018)

Mechanisms by Which Atopic Dermatitis Predisposes to Food Allergy and the Atopic March
por: Tham, Elizabeth Huiwen, et al.
Publicado: (2018)

Diversity of Tanaidacea (Crustacea: Peracarida) in the World's Oceans – How Far Have We Come?
por: Blazewicz-Paszkowycz, Magdalena, et al.
Publicado: (2012)

Review of Two Decades of Cholera Diagnostics – How Far Have We Really Come?
por: Dick, Michal H., et al.
Publicado: (2012)

Oncolytic virotherapy using herpes simplex virus: how far have we come?
por: Sokolowski, Nicolas AS, et al.
Publicado: (2015)

Training in robotic surgery, replicating the airline industry. How far have we come?
por: Collins, Justin William, et al.
Publicado: (2019)

Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next?
por: Jones, Katelyn, et al.
Publicado: (2020)

Microfluidic Platforms to Unravel Mysteries of Alzheimer’s Disease: How Far Have We Come?
por: Prasanna, Pragya, et al.
Publicado: (2021)

The Role of E-Content Development in Medical Teaching: How Far Have We Come?
por: Bankar, Maithili N, et al.
Publicado: (2023)

Identification of predictors for persistence of immediate-type egg allergy in Chinese children
por: Ngai, Noelle Anne, et al.
Publicado: (2021)

In Search of a Data-in-Once, Electronic Health Record-Linked, Multicenter Registry—How Far We Have Come and How Far We Still Have to Go
por: Marsolo, Keith
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ltuojjqp765eo94oeqe1djp85q